These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9235578)

  • 1. [Clinical and bacteriological features of intestinal dysbacteriosis in patients with pulmonary tuberculosis].
    Lineva ZE
    Probl Tuberk; 1997; (2):27-8. PubMed ID: 9235578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immune responsive features in patients with pulmonary tuberculosis complicated by intestinal dysbacteriosis].
    Lineva ZE
    Probl Tuberk; 1997; (2):32-3. PubMed ID: 9235581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. THE ROLE OF CANDIDA IN INTESTINAL DYSBACTERIOSIS FORMATION.
    Lineva ZE; Gulyaeva NA; Romanova MV; Dyachkovskaya PS
    Wiad Lek; 2015; 68(4):543-5. PubMed ID: 26887132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and bacteriological manifestations of nonspecific infection of the urinary tract and dysbacteriosis in patients with tuberculosis of the kidneys].
    Kaliuk AN; Danilova NK; Strel'nikova VA
    Ter Arkh; 1987; 59(12):6-9. PubMed ID: 3128884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Large intestine dysbacteriosis and therapy efficacy in patients with respiratory tract tuberculosis in sanatoria].
    Dugina NN; Chebotareva TV; Mitrokhin SD
    Antibiot Khimioter; 2004; 49(4):35-8. PubMed ID: 15460021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of radon therapy on the bacteriological and immunological indices of patients with intestinal dysbacteriosis].
    Marshalik BE; Shkolenko RL
    Vopr Kurortol Fizioter Lech Fiz Kult; 1993; (5):30-4. PubMed ID: 8266665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathogenetic mechanisms of impaired intestinal microflora in patients with destructive pulmonary tuberculosis].
    Lineva ZE; Tiaptirgianova NG
    Probl Tuberk; 2001; (2):13-4. PubMed ID: 11490455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Frequency and pattern of adverse reactions due to treatment of patients with pulmonary tuberculosis with antitubercular reserve drugs].
    Chukanov VI; Kaminskaia GO; Livchane E
    Probl Tuberk Bolezn Legk; 2004; (10):6-10. PubMed ID: 15568310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Distribution of intestinal dysbacteriosis among children].
    Krivogorskiĭ EB; Meshcherekova KM; Malkina RD; Mikitina RV
    Vopr Okhr Materin Det; 1974 May; 19(5):89. PubMed ID: 4464651
    [No Abstract]   [Full Text] [Related]  

  • 10. [The microbiological characteristics of intestinal dysbacteriosis in children and adults in the city of Moscow].
    Likhoded VG; Kaverina KG; Kochurko LI; Lobova EA
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (4):65-7. PubMed ID: 10852056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Microbial intestinal biocenosis in lingering and complicated course of community pneumonia].
    Osipov MIu; Bilev AE; Osipov IuA
    Ter Arkh; 2008; 80(2):52-7. PubMed ID: 18372597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Periarteritis nodosa in patients with pulmonary tuberculosis].
    Savula MM; Mokritskiĭ RM
    Probl Tuberk; 1975; (9):80-2. PubMed ID: 6957
    [No Abstract]   [Full Text] [Related]  

  • 13. [Increased antibody titers to bifidobacteria as a marker of intestinal dysbacteriosis].
    Anikhovskaia IA; Vyshegurov IaKh; Likhoded VG; Iakovlev MIu
    Fiziol Cheloveka; 2005; 31(2):132-4. PubMed ID: 15889831
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical evaluation on the duration of hospitalization for patients with pulmonary tuberculosis].
    Inoue T; Tanaka E; Oida K; Taguchi Y; Kato T; Sakuramoto M; Maeda Y; Maniwa K
    Kekkaku; 2003 Feb; 78(2):79-82. PubMed ID: 12664444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Features of isoniazid activation in patients with tuberculosis and diabetes mellitus].
    Karachunskiĭ MA; Kaminskaia GO; Kossiĭ IuE; Chernykh NA
    Probl Tuberk; 2001; (7):26-7. PubMed ID: 11763557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Manifestations of colonic dysbacteriosis in patients with drug-resistant respiratory tuberculosis].
    Tsygina TIu; Chebotareva TV
    Tuberk Biolezni Legkih; 2009; (12):62-8. PubMed ID: 20095376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of non-tuberculous pulmonary mycobacteriosis].
    Sakatani M; Nakajima Y
    Kekkaku; 2006 Jan; 81(1):35-50. PubMed ID: 16479999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The specific features of the detection, clinical manifestations, and treatment of tuberculosis in the HIV-infected].
    Erokhin VV; Kornilova ZKh; Alekseeva LP
    Probl Tuberk Bolezn Legk; 2005; (10):20-8. PubMed ID: 16318255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bacteriological and serological research on patients with destructive pulmonary tuberculosis complicated by a nonspecific infection].
    Selina LG; Dadasheva AK; Reznikova LI
    Probl Tuberk; 1986; (4):57-60. PubMed ID: 3520548
    [No Abstract]   [Full Text] [Related]  

  • 20. [The dysbacteriosis of extreme states].
    Liz'ko NN
    Antibiot Med Biotekhnol; 1987 Mar; 32(3):184-6. PubMed ID: 3579245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.